From: Surgical ablation for atrial fibrillation: impact of Diabetes Mellitus type 2
 | Group I (Non-DM) | Group II (DM) | p Value |
---|---|---|---|
N | 484 | 122 | Â |
Age | 69 (62–75.3) | 65 (57–72) |  < 0.001 |
Male gender (n, %) | 259 (53.5%) | 71 (58.2%) | 0.362 |
Elective surgery (n, %) | 437 (90.3%) | 104 (85.2%) | 0.182 |
NIHA III-IV (n, %) | 179 (37%) | 44 (36.1%) | 0.454 |
Previous cardiac surgery (n, %) | 40 (8.3%) | 5 (4.1%) | 0.127 |
EF (%) | 60 (51.5–60) | 60 (53–60) | 0.618 |
LVEDD (cm) | 5 (4.5–5.5) | 5.1 (4.6–5.6) | 0.136 |
Left atrial volume (cm3) | 113 (81–151) | 123 (93–163) | 0.054 |
Left ventricular dysfunction | |||
 Moderate (n, %) | 19 (3.9%) | 8 (6.6%) | 0.651 |
 Severe (n, %) | 6 (1.2%) | 2 (1.6%) | |
Paroxysmal AF | 279 (57.6%) | 68 (55.7%) | 0.376 |
Persistent AF | 149 (30.8%) | 45 (36.9%) | 0.76 |
Long-standing and permanent AF | 56 (11.6%) | 9 (7.4%) | 0.231 |
Arterial hypertension (n, %) | 288 (59.5%) | 104 (85.2%) |  < 0.001 |
COPD (n, %) | 30 (6.2%) | 14 (11.5%) | 0.052 |
Dialysis (n, %) | 1 (0.2%) | 0 (0%) | 1.000 |
Hyperlipidemia (n, %) | 244 (50.4%) | 92 (75.4%) |  < 0.001 |
PVD (n, %) | 20 (4.1%) | 6 (4.9%) | 0.614 |
CVA/TIA (n, %) | 46 (9.5%) | 19 (15.6%) | 0.048 |
Pulmonary hypertension (n, %) | 90 (18.6%) | 19 (15.6%) | 0.509 |
HA1C (%) | 6.5 (5.9–7.3) | 5.6 (5.3–5.8) |  < 0.001 |
Standard EuroSCORE I | 5 (4–7) | 5 (3–6) | 0.001 |
Logistic EuroSCORE I (%) | 4.5 (2.7–8.1) | 3.7 (2.1–5.8) | 0.010 |